Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Circadian locomotor output cycles protein kaput (CLOCK) is a core transcription factor in the molecular circadian clock system. It forms a heterodimer with BMAL1, and this complex drives expression of PER and CRY genes by binding E-box elements in target gene promoters, generating the feedback loops that maintain circadian rhythms in mammalian physiology[1][2]. CLOCK is also a histone acetyltransferase, providing chromatin-regulatory functions that are essential for rhythmic gene transcription[1]. Its activity modulates processes such as sleep/wake timing, hormone secretion, metabolism, inflammation, DNA repair, and the cell cycle[2]. Dysfunction of CLOCK has been linked to cancer, neurodegeneration, cardiovascular and metabolic diseases, and inflammatory pathologies[2]. Drugs directly targeting CLOCK are experimental, but manipulation of its pathway has potential therapeutic utility; however, risks include widespread biological disruption given its centrality to human physiology[2].
Direct or indirect inhibition of CLOCK/BMAL1 activity; Modulation of transcription or acetylation activity affecting downstream circadian output
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Circadian locomotor output cycles protein kaput (CLOCK).